학술논문
FGF-2 targets sclerostin in bone and myostatin in skeletal muscle to mitigate the deleterious effects of glucocorticoid on musculoskeletal degradation
Document Type
Article
Author
Source
In Life Sciences 15 July 2019 229:261-276
Subject
Language
ISSN
0024-3205